Loading provider…
Loading provider…
Cardiovascular Disease Physician in Delray Beach, FL
NPI: 1073764718Primary Practice Location
DELRAY MEDICAL CENTER
5352 Linton Blvd, Delray Beach, FL
Primary Employer
South Palm Cardiovascular Associates LLC
southpalmcardiovascular.com
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2011 - 2027
NY State Medical License
2005 - 2013
MA State Medical License
2003 - 2006

American Board of Internal Medicine
Cardiovascular Disease

American Board of Internal Medicine
Interventional Cardiology

American Board of Nuclear Medicine
Nuclear Cardiology

American Board of Vascular Medicine
Endovascular Medicine

American Board of Vascular Medicine
Vascular Medicine
Harvard Medical School
hms.harvard.edu
Medical School
Until 2000
Yale School of Medicine
medicine.yale.edu
BS • MS
1992 - 1996
New York Presbyterian Hospital (Columbia Campus)
Fellowship • Interventional Cardiology
2008 - 2011
Fellowship • Cardiovascular Disease
2005 - 2008
Mass General Brigham/Massachusetts General Hospital
Fellowship • Cardiovascular Disease
2003 - 2005
Residency • Internal Medicine
2001 - 2003
Johns Hopkins University
Internship • Internal Medicine
2000 - 2001
Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia
Authors: Sabatine, Marc S, Liu, Emerson, Morrow, David A, Heller, Eric, McCarroll, Robert, Wiegand, Roger, Berriz, Gabriel F, Roth, Frederick P, Gerszten, Robert E
Journal: Circulation
Publication Date: 2005-12-12
Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival.
Authors: Liu, Emerson, Sinha, Sumita, Williams, Christine, Cyrille, Marcoli, Heller, Eric, Snapper, Scott B, Georgopoulos, Katia, St-Arnaud, Rene, Force, Thomas, Dedhar, Shoukat, Gerszten, Robert E
Journal: Mol Cell Biol
Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
Authors: Karen S. Moulton, Eric A. Heller, Moritz A. Konerding, Evelyn Flynn, Wulf Palinski, Judah Folkman
Publication Date: 1999-04
Lead Sponsor: Abbott Medical Devices
Intervention / Treatment: DEVICE: Any Abiomed Impella® device approved for use in high-risk PCI, DEVICE: HeartMate PHP
Lead Sponsor: Direct Flow Medical, Inc.
Intervention / Treatment: DEVICE: Commercially Available, DEVICE: Direct Flow Medical
Lead Sponsor: Cordis Corporation